Celldex Therapeutics(CLDX) - 2025 Q4 - Annual Results

Celldex Reports Fourth Quarter and Year End 2025 Financial Results and Provides Corporate Update EXHIBIT 99.1 HAMPTON, N.J., Feb. 25, 2026 (GLOBE NEWSWIRE) -- Celldex (NASDAQ:CLDX) today reported financial results for the fourth quarter and year ended December 31, 2025 and provided a corporate update. "The enthusiasm for barzolvolimab continues to build, driven by unparalleled efficacy data across multiple indications," said Anthony Marucci, Co-founder, President and Chief Executive Officer of Celldex. "Thi ...